Ladarvision Excimer Laser System
FDA premarket approval P970043 · Excimer laser system
Approval
- Applicant
- Alcon Laboratories
- Received
- September 5, 1997
- Decision date
- November 2, 1998 (APWD)
- Supplements
- 23, latest November 1, 2006
- Product code
- LZS – Excimer Laser System
Approval order statement
Indicated for use in photorefractive keratectomy (PRK) treatment for the reduction or elimination of mild to moderate myopia in patients with the following three characteristics: 1) between -1.00D to -10.00D of sphere and less than or equal to -4.00D of astigmatism at the spectacle plane, the combination of which must result in an attempted correction between -0.50D and -10.00D spherical equivalent (SE) at the spectacle plane where sphere or cylinder is at least 1.00D; 2) who are 21 years of age or older; and 3) with documented stability of refraction for the prior 12 months, as demonstrated by a change of less than or equal to 0.50D for corrections up to -7.00D SE, and less than or equal to -1.00D for corrections greater than -7.00 D SE.